15d-PGJ2 alleviates ConA-induced acute liver injury in mice by up-regulating HO-1 and reducing hepatic cell autophagy

Biomed Pharmacother. 2016 May:80:183-192. doi: 10.1016/j.biopha.2016.03.012. Epub 2016 Mar 26.

Abstract

Objective: In this study, we confirmed a protective effect of 15d-PGJ2 in concanavalin A (ConA)-induced fulminant hepatitis in mice and investigated the potential mechanism.

Materials and methods: Balb/C mice were injected with ConA (25mg/kg) to induce acute fulminant hepatitis, and 15d-PGJ2 (2.5-10μg) was administered 30min after the ConA injection. The histological grade, pro-inflammatory cytokine and ROS levels, apoptosis and autophagy activity, the expression of HO-1, Nrf2, JNK and Bcl-2 activity were determined 2, 4, and 8h after the ConA injection.

Results: Following ConA challenge, the expression of cytokines tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β) was up-regulated. Treatment with 15d-PGJ2 reduced the pathological effects of ConA-induced fulminant hepatitis and significantly reduced the levels of TNF-α, IL-1β and ROS after injection. 15d-PGJ2 inhibited apoptosis and autophagic cell death, facilitated Nrf2 nuclear translocation, increased HO-1 expression and suppressed the JNK activation.

Conclusion: 15d-PGJ2 alleviates ConA-induced acute liver injury in mice by up-regulating the anti-oxidative stress factor HO-1 and reducing the production of cytokines and ROS, thereby inhibiting hepatic cell autophagy probably induced by ROS.

Keywords: 14-prostaglandin J2; 15-Deoxy-Δ12; Autophagy; Concanavalin A; HO-1; Nrf2.

MeSH terms

  • Acute Disease
  • Animals
  • Autophagy / drug effects*
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Concanavalin A
  • Disease Models, Animal
  • Enzyme Activation / drug effects
  • Heme Oxygenase-1 / metabolism*
  • Hepatitis / drug therapy
  • Hepatitis / pathology
  • Hepatocytes / drug effects
  • Hepatocytes / pathology*
  • Hepatocytes / ultrastructure
  • Interleukin-1beta / metabolism
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Liver / drug effects
  • Liver / injuries*
  • Liver / pathology*
  • Liver / ultrastructure
  • Male
  • Mice, Inbred BALB C
  • NF-E2-Related Factor 2 / metabolism
  • Phagosomes / drug effects
  • Phagosomes / metabolism
  • Phagosomes / ultrastructure
  • Prostaglandin D2 / analogs & derivatives*
  • Prostaglandin D2 / pharmacology
  • Prostaglandin D2 / therapeutic use
  • Reactive Oxygen Species / metabolism
  • Tumor Necrosis Factor-alpha / metabolism
  • Up-Regulation / drug effects*

Substances

  • 15-deoxyprostaglandin J2
  • Interleukin-1beta
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Concanavalin A
  • Heme Oxygenase-1
  • JNK Mitogen-Activated Protein Kinases
  • Prostaglandin D2